Notes from the field: Use of tetanus, diphtheria, and pertussis vaccine (Tdap) in an emergency department - Arizona, 2009-2010

Morbidity and Mortality Weekly Report

Volumn 61, Issue 3, 2012, Pages 55-56

  Rhodes, Suzanne Michelle ^a   Hiller, Katherine ^a   Stolz, Uwe ^a   Hays, Dan ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; TETANUS TOXOID;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; IMMUNIZATION; IMMUNOLOGY; MALE; MIDDLE AGED; PERTUSSIS; PRACTICE GUIDELINE; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ARIZONA; CHILD; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; EMERGENCY SERVICE, HOSPITAL; FEMALE; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; IMMUNIZATION; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; TETANUS TOXOID; WHOOPING COUGH;

EID: 84856420627     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. CDC. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR 2006;55 (No. RR-17).
2. CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR 2011;60:13-5.